Latest Updates Around The World
Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded on a mission to discover, develop and commercialize innovative, first-in-class medicines that address significant unmet medical needs, today announced it will hold a conference call on Thursday, October 30, 2025 at 4:30 PM Eastern Time to discuss financial results and provide a third quarter business update from […]
Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded on the mission to discover, develop and commercialize innovative, first-in-class medicines that address significant unmet medical needs, today announced the appointment of Sue Hohenleitner as Chief Financial Officer (CFO), effective November 4, 2025. Ms. Hohenleitner is a proven financial leader, with more than 30 years of experience […]
